BIOTRONIK Creates Broader, Stronger PTA Balloon Portfolio

New high-pressure percutaneous transluminal angioplasty (PTA) balloon lengths offer physicians the potential to dilate longer disease segments in lower limb vessels with fewer balloon inflations.

The Passeo-35 HP 0.9 mm PTA balloon is designed to treat vessel segments that require high pressure (HP) dilatation to efface resistant, often fibrotic stenosis, which are commonly encountered in arteriovenous (AV) access fistulae and grafts. The flexible balloon material is designed to conform to vessel curvature, minimizing vessel straightening during HP inflations. The Passeo-35 HP design aims to minimize axial and radial balloon expansion, avoiding excessive barotraumas, and providing excellent stability during inflation at high-rated burst pressures of up to 2735.7 kPa (27 atmospheres).


The BIOTRONIK Passeo-35 PTA balloon line extension and the Passeo-35 HP PTA balloon, intended for AV dialysis fistulae applications, are now available in lengths of up to 200 mm and in diameters of 3–7 mm. The new additions could help reduce potential barotrauma caused by multiple inflations, and may shorten procedure times. In addition, the Passeo-35 line has an extremely low profile, allowing for balloon compatibility with a 1.67 mm introducer sheath, and an excellent secondary profile.

The Passeo-35 line also has excellent synergies with other 0.889 mm guide wire compatible devices in the portfolio, such as the Dynamic Balloon Expandable Stent, the Astron Self Expanding Stent, and the Pulsar-35 Self Expanding Stent. The Passeo-35 HP is available in diameters from 3–12 mm and in balloon lengths from 20–100 mm. The Passeo-35 PA and Passeo-35 HP line of products is made by BIOTRONIK (Buelach, Switzerland).

“These latest additions to our unique peripheral intervention portfolio underline BIOTRONIK’s commitment to delivering dedicated, innovative devices in line with the needs and expectations of interventional operators,” said Alexander Uhl, vice president of marketing for vascular intervention at BIOTRONIK. “Furthermore, our PTA balloon portfolio is now one of, if not the, strongest and most comprehensive available.”

Related Links:
BIOTRONIK